Publication | Open Access

Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment

Tumor BiologyGastric Cancer TreatmentOncologyMedicineTumor GrowthDiallyl TrisulfideAnti-cancer AgentTumor SuppressorCancer TreatmentPharmacologyCell BiologyCancer Research